Drug­maker Per­rigo won’t con­firm whether its CEO will take the top job at trou­bled Valeant Phar­ma­ceu­ti­cals.

Modern Healthcare - - LATE NEWS -

The Wall Street Jour­nal has re­ported that Valeant is fi­nal­iz­ing a con­tract with Per­rigo Chair­man and CEO Joseph Papa and could an­nounce the hire this week. Per­rigo said it would not com­ment on “spec­u­la­tion or mar­ket ru­mor.” Valeant is un­der scru­tiny for its strat­egy of buy­ing small drug­mak­ers, then rais­ing prices sharply on older, off­patent drugs. In March, Valeant said it would re­place CEO Michael Pear­son af­ter bil­lions evap­o­rated from the com­pany’s worth.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.